Publications And Abstracts

PUBLICATIONS


  • Dejaco C, Singh YP, Perel P, Hutchings A, Matteson EL, Dasgupta B et al. 2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative.Ann Rheum Dis 2015;74:1799-1807 doi:10.1136/annrheumdis-2015-207492
  • Dejaco C, Singh YP, Perel P, Hutchings A, Matteson EL, Dasgupta B et al.2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative.Arthritis & Rheumatology2015 ,67(10) 2569–2580.
  • Dejaco C, Singh YP, Perel P, Hutchings A, Matteson EL, Dasgupta B et al.Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatic: a systematic literature review informing the 2015 EULAR-ACR recommendations for the management of polymyalgia rheumatic. Ann Rheum Dis. 2015 Oct;74(10):1808-17. doi: 10.1136/annrheumdis-2015-207578.
  • Arthritis in sarcoidosis – a multi-centre study. Vikas Agarwal, Abhra Chandra Chowdhury, Parasar Ghosh, Sundeep Grover, Dhanita Khanna, Durga Prasanna Misra, Alok Nath, Sapan Pandya, Shiva Prasad, Vishnu Vardhan Reddy, Pradip Sarma, Aman Sharma, Padmanabha Shenoy, Banwari Sharma, Yogesh Singh, Anupam Wakhlu. International Journal of Rheumatic Diseases; 18 (Suppl. 1) P41.
  • Dejaco C, Singh Y, Perel P, Hutchings A, Matteson EL, Dasgupta B. Current evidence on prognostic factors in patients with polymyalgia rheumatic (PMR): A systematic literature review informing the ACR/EULAR recommendations for the management of PMR. Ann Rheum Dis 2014;73(Suppl2).
  • Dejaco C, Singh Y, Perel P, Hutchings A, Matteson EL, Dasgupta B on behalf of ACR/EULAR guidelines development group. Current evidence for the therapeutic intervention in polymyalgia rheumatic (PMR): A systematic review informing the ACR/EULAR recommendations for the management of PMR. Ann Rheum Dis 2014;73(Suppl2).
  • Singh Y, Dejaco C, Perel P, Hutchings A, Matteson EL, Dasgupta B on behalf of ACR/EULAR guidelines development group. Polymyalgia Rheumatica: Prioritisation of Outcome Measures e Perspective of Patients, General Practitioners and Rheumatologists. Indian Journal of Rheumatology 2013;8;S3.
  • Singh Y, Achilleos K, Patil P, Longhurst H, Clarke G, Dasgupta B. Isolated Anti-Ro52 Antibody – Significance and Clinical Association. Indian Journal of rheumatology 2013;8;S29.
  • Singh Y, Dejaco C, Perel P, Hutchings A, Matteson EL, Dasgupta B on behalf of ACR/EULAR guidelines development group. Developing Guideline for Polymyalgia Rheumatica: Prioritisation of Outcome Measures – Perspective of Patients, General Practitioners and Rheumatologists. Arthritis and rheumatism 2013;65(10) S703.
  • Singh Y, Patil P, Longhurst H, Clarke G, Dasgupta B. Isolated Anti-Ro52 Antibody – Significance and Clinical Association. Arthritis and rheumatism 2013;65(10) S869
  • Dhir V, Singh YP, Misra R, AggarwalA.Central nervous system tuberculosis: mimicking neuropsychiatric systemic lupus erythematosus. J ClinRheumatol. 2012 Mar;18(2):113-4.
  • Singh YP, Aggarwal A. A modified Juvenile Arthritis Damage Index to improve articular damage assessment in Juvenile idiopathic arthritis – Enthesitis-related arthritis (JIA-ERA). Clinical Rheumatology 2012; DOI:10.1007/s10067-011-1928-6.(epub)
  • Myles A, Vishad V, Singh YP, Aggarwal A. Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. Journal of Rheumatology 2011;38(9):1994-9
  • Bains S, Singh YP, Sharma K, Aggarwal A. Keratoconjunctivitis sicca and juvenile idiopathic arthritis. Indian Journal of Rheumatology 2011;6(3) S17.
  • Singh YP, Shivaprasad BN, AgarwalV. An unusual cause of anaemia in scleroderma: Gastric antral vascular ectasia. Indian Journal of Rheumatology 2011;6(3):158 – 163.
  • Prasada R, Singh YP, Agarwal V, Paliwal VK, Marak RS, Gupta RK. Cryptococcal meningitis in systemic lupus erythematosus—Magnetic resonance imaging is not good. Indian Journal of Rheumatology 2011;6(1): 50-52
  • Aggarwal A, Myles A, ViswanathV, Singh YP. Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. Pediatric Rheumatology 2011, 9(Suppl 1): P179
  • Singh YP, Singh AK, Aggarwal A, Misra RN. Evidence of cellular immune response to an outer membrane protein of Salmonella typhimurium in patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Journal of Rheumatology 2011;38(1):161-166 .
  • Singh YP, Aggarwal A. Disease phenotype in adults with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Indian Journal of Rheumatology 2010;5(3) S9.
  • Singh YP, Shivaprasad BN, Aggarwal A, Lawrence A, Misra R, Agarwal V. Methotrexate-induced pancytopenia: Need for increased awareness amongst Primary care physicians.Indian Journal of Rheumatology 2010;5(3) S19.
  • Vishwanath V, Singh YP, Lawrence A, Agarwal V, Misra R, Aggarwal A. Male Lupus: A retrospective data review. Indian Journal of Rheumatology 2010;5(3) S19.
  • Singh YP, AggarwalA.Immune response to an outer membrane protein of Enterobacteriaceae in patients with enthesitis-related arthritis. International Journal of Rheumatic Diseases 2010; 13 (Suppl. 1): 59–60.
  • Singh YP, Aggarwal A. Is there a need to modify juvenile arthritis damage index (JADI) for damage assessment in Juvenile idiopathic arthritis – Enthesitis-related arthritis (JIA-ERA)? International Journal of Rheumatic Diseases 2010; 13 (Suppl. 1): 198–202.
  • Singh YP, Singh AK, Aggarwal A, Misra RN. Immune response to an outer membrane protein of S. Typhimurium in patients with JIA-ERA. Indian Journal of Rheumatology 2009; 4(3): S6.
  • Singh YP, Srivastava R, Aggarwal A. Can JADI be used for damage assessment in JIA-ERA ( juvenile idiopathic arthritis–enthesitis related arthritis)? Indian Journal of Rheumatology 2009; 4(3): S24.
  • Viswanath V, Singh YP, Lawrence A, Agarwal V, Misra RN, AggarwalA.Serious infections are SLE: a retrospective analysis of 288 patients. Indian Journal of Rheumatology 2009; 4(3):S24.
  • Srivastava R, Singh YP, Misra RN, Aggarwal A. Prevalence of HLA B27 in patients with enthesitis-related arthritis (ERA) from of JIA. Indian Journal of Rheumatology 2009; 4(3):S18.
  • Singh YP, Aggarwal A, Misra RN. To assess the functional outcome of juvenile idiopathic arthritis– enthesitis related arthritis (JIA-ERA). Modern Rheumatology 2009;19 (S157).
  • Dhir V, Chaudhary GD, Singh YP, Lawrence A, Aggarwal A, Misra R. Medical image. A case of lumbodynia. N Z Med J. 2009;122:115-7
  • Singh YP, Agarwal V, Krishnani N, Misra RN. Enthesitis-related arthritis in Kikuchi–Fujimoto disease. Modern Rheumatology 2008; 18:492–495.
  • Agrawal S, Singh YP, Kumari N, Kashyap R, Aggarwal A, Misra RN. Rheumatoid arthritis and primary CNS lymphoma. Journal of Clinical Rheumatology 2008; 14:54-5.
  • Singh YP, Misra RN, Aggarwal A. Excellent response to infliximab in a patient with refractory cutaneous PAN. Indian Journal of Rheumatology 2008; 3(3):S39.
  • Singh YP, Sarma PK, Agarwal V, Lawrence A, Aggarwal A, Misra RN. Wegener’s granulomatosis: experience at a tertiary care centre. Indian Journal of Rheumatology 2007; 2(3):S5.
  • Singh YP, Aggarwal A. Joint involvement in Dengue fever. Journal of General Practice 2007; 19: 35-6.
  • Singh YP, Misra RN, Aggarwal A, Aggarwal V. Low dose methotrexate-induced pancytopenia. Clinical Rheumatology 2007; 26: 84–87.
  • Singh YP, Grover S, Gupta RK, Krishnani N, Aggarwal V. Eosinophilic fasciitis. Journal Indian Rheumatology Association 2005; 13: 175-76.

OTHER EXPERIENCE


  • Part of the ACR and EULAR guidelines panel for treatment recommendations in the management of polymyalgia rheumatic. (ACR – American College of rheumatology; EULAR – European league against rheumatism)